The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management

Journal of Applied Physiology

Volumn 108, Issue 2, 2010, Pages 227-237

  Esler, Murray ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Cardiac failure; Hypertension; Norepinephrine; Orthostatic intolerance; Stress

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ADRENERGIC SYSTEM; ANIMAL; CARDIOVASCULAR DISEASE; DRUG EFFECT; HUMAN; MENTAL DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; MENTAL DISORDERS; NEUROTRANSMITTER AGENTS; SYMPATHETIC NERVOUS SYSTEM;

EID: 75749150916     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00832.2009     Document Type: Review

References (101)

1. Abdulla I, Ward MR. Tako-tsubo cardiomyopathy: how stress can mimic acute coronary occlusion. Med J Aust 187: 357-360, 2007.
2. The Ad Hoc Syncope Consortium, Benditt DG. The ACCF/AHA scientific statement on syncope. A document in need of thoughtful revision. Clin Autonom Res 16: 363-368, 2006.
3. Albert CM, Chae CU, Rexrode KM, Manson JE, Kawachi I. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation 111: 480-487, 2005. (Pubitemid 40204433)
4. Aloe L, Bracci-Laudiero L, Alleva E, Lambiase A, Micera A, Tirassa P. Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor in lymphocytes. Proc Natl Acad Sci USA 91: 10440-10444, 1994. (Pubitemid 24329013)
5. Alvarenga ME, Richards JC, Lambert G, Esler MD. Psychophysiological mechanisms in panic disorder: a correlative analysis of noradrenaline spillover, neuronal noradrenaline reuptake, power spectral analysis of heart rate variability and psychological variables. Psychosom Med 68: 8-16, 2006. (Pubitemid 43803210)
6. Barton DA, Dawood T, Lambert EA, Esler MD, Haikerwal D, Hotchkin E, Brenchley C, Socratous F, Kaye DM, Schlaich MP, Hickie I, Lambert GW. Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens 25: 2117-2124, 2007.
7. Biaggioni I. Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension? Hypertension 51: 168-171, 2008. (Pubitemid 351159921)
8. Brunner-La Rocca HP, Esler MD, Jennings GL, Kaye DM. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J 22: 1136-1143, 2001. (Pubitemid 32666655)
9. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sagerman WS, Liuie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and ß-adrenergic receptor density in failing human hearts. N Engl J Med 307: 205-211, 1982. (Pubitemid 12079105)
10. Bunker SJ, Colquhoun DM, Esler MD, Hickie IB, Hunt D, Jelinek M, Oldenburg BF, Peach HG, Ruth D, Tennant CC, Tonkin AM. Stress and coronary heart disease: psychological risk factors. National Heart Foundation of Australia position statement update. Med J Aust 178: 272-276, 2003. (Pubitemid 36382992)
11. Burgdorf C, von Hof K, Schunkert H, Kurowski V. Regional alterations in myocardial sympathetic innervation in patients with transient left-ventricular apical, ballooning (Tako-Tsubo cardiomyopathy). J Nucl Cardiol 15: 65-72, 2008. (Pubitemid 351168511)
12. Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal, failure. Hypertension 25: 878-882, 1995.
13. Cannon WB. Bodily Changes in Pain, Hunger, Fear and Rage. New York: Appleton, 1929.
14. Chandola T, Brunner E, Marmot M. Chronic stress at work and the metabolic syndrome. Br Med J 332: 521-524, 2006.
15. Chidsey CA, Braunwald E, Morrow AG, Mason DT. Myocardial norepinephrine concentration in man: effects of reserpine and of congestive heart failure. N Engl J Med 269: 653-658, 1963.
16. Cohn J, Levine T, Olivan MT, Garberg V, Tura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with congestive heart failure. N Engl J Med 311: 819-823, 1984. (Pubitemid 14035089)
17. Converse RL, Jacobsen TN, Toto RD, Jost CM, Cosentino F, FouadTarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327: 1912-1918, 1992.
18. Davies SJ, Ghahramani P, Jackson PR, Noble TW, Hardy PG, Hippislet-Cox J, Yeo WW, Ramsay LE. Association of panic disorder and panic attacks with hypertension. Am J Med 107: 310-316, 1999. (Pubitemid 29465807)
19. Dawood T, Lambert EA, Barton DA, Laude D, Elghozi JL, Esler MD, Haikerwal H, Kaye DM, Hotchkin EJ, Lambert GW. Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel, markers of cardiac risk. Hypertens Res 30: 285-293, 2007. (Pubitemid 46779976)
20. DiBona GF, Kopp UC. Neural control of renal, function. Physiol Rev 77: 75-197, 1997. (Pubitemid 27069290)
21. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, Kopin IJ, Goldstein DS, Esler MD. Cardiac sympathetic nerve function in congestive heart failure. Circulation 93: 1667-1676, 1996. (Pubitemid 26131343)
22. Elliott TR. The action of adrenaline. J Physiol 32: 401-467, 1905.
23. Engelman K, Portnoy B, Lovenberg W. A sensitive and specific double isotope derivative method for the determination of catecholamines in biological specimens. Am J Med Sci 255: 259-268, 1968.
24. Esler M, Jennings G, Korner P, Blombery P, Sacharias N, Leonard P. Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol Endocrinol Metab 247: E21-E28, 1984. (Pubitemid 14096121)
25. Esler M, Hasking G, Willett I, Leonard P, Jennings G. Noradrenaline release and sympathetic nervous system activity. J Hypertens 3: 117-129, 1985. (Pubitemid 15117564)
26. Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, Anderson W, Lambert G. The assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11: 3-20, 1988. (Pubitemid 18086305)
27. Esler M, Jennings G, Lambert G. Measurement of overall, and cardiac norepinephrine release into plasma during cognitive challenge. Psychoneuroendocrinology 14: 477-481, 1989. (Pubitemid 20033116)
28. Esler M, Lambert G, Jennings G. Regional norepinephrine turnover in human hypertension. Clin Exp Hypertens 11, Suppl 1: 75-89, 1989.
29. Esler M, Jennings G, Lambert G, Meredith I, Home M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions. Physiol Rev 70: 963-985, 1990. (Pubitemid 20364820)
30. Esler M, Kaye D, Lambert G, Esler D, Jennings G. Adrenergic nervous system in heart failure. Am J Cardiol 80: 7L-14L, 1997.
31. Esler M. Looking at the sympathetic nervous system as a primary source. Handbook of Hypertension: Hypertension research in the Twentieth Centuiy, edited by Zanchetti A, Robertson JIS, and Birkenhager WH. Amsterdam: Elsevier, 2004, p. 81-103.
32. Esler M, Alvarenga M, Lambert G, Kaye D, Hastings J, Jennings G, Morris M, Schwarz R, Richards J. Cardiac sympathetic nerve biology and brain, monoamine turnover in panic disorder. Ann NYAcad Sci 1018: 505-514, 2004.
33. Esler M, Stranicky N, Eikelis N, Masuo K, Lambert G, Lambert E. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 48: 787-796, 2006. (Pubitemid 44610980)
34. Esler M, Eikelis N, Schlaich M, Lambert G, Alvarenga M, Dawood T, Kaye D, Barton D, Pier C, Guo L, Brenchley C, Jennings G, Lambert E. Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress. Clin Exp Pharmacol Physiol 35: 498-502, 2008.
35. Esler M, Schwarz R, Alvarenga M. Mental Stress is a cause of cardiovascular diseases: from skepticism to certainty. Stress Health 24: 175-180, 2008.
36. Franklin KJ. A Short History of Physiology. London: Bale, 1933.
37. Frasure-Smith N, Lesperance F, Talajiic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 270: 1819-1861, 1993.
38. Geser F, Wenning GK. Primary autonomic failure. In: Neurology and Clinical Neuroscience, edited by Schapira AHV. Philadelphia, PA: Mosby, 2007, p. 372-393.
39. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwarz P, Bigger JT JR, Krishnan KRR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288: 701-709, 2002.
40. Goldstein DS, Holmes C, Cannon RO III, Eisenhofer G, Kopin iJ. Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 336: 696-702, 1997.
41. Goldstein DS, Holmes C, Frank SM, Dendi R, Cannon RO 3rd, Sharabi Y, Esler MD, Eisenhofer G. Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation 106: 2358-2365, 2002.
42. Goldstein DS. Adrenaline and the Inner World. Baltimore, MD: Johns Hopkins University Press, 2006.
43. Grassi G, Colombo M, Seravalle G, Spaziani D, Maneia G. Dissociation between, muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension 31: 64-67, 1998. (Pubitemid 28124693)
44. Grassi G, Seravalle G, Dell'Oro R, Trevano F, Bombelli M, Scopelliti F, Facchini A, Mancia G. Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study. J Hypertens 21: 1761-1769, 2003. (Pubitemid 37076361)
45. Grassi G, Dell'Oro R, Quarti-Trevano F, Scopelliti F, Seravalle G, Paleari F, Gamba PL, Manci G. Neuroadrenergic and reflex abnormalities in patients with the metabolic syndrome. Diabetologia 48: 1359-1365, 2005. (Pubitemid 41186102)
46. Greenwood JP, Stocker JB, Mary DASG. Single-unit sympathetic discharge. Quantitative assessment in human hypertensive disease. Circulation 100: 1305-1310, 1999.
47. Hagbarth KE, Vallbo AB. Pulse and respiratory grouping of sympathetic impulses in human muscle nerves. Acta Physiol Scand 74: 96-106, 1968.
48. Hamilton WF, Richards DW. Output of the heart. In: Circulation of the Blood. Men and Ideas, edited by Fishman AP and Richards DW. Bethesda, MD: Am. Physiol. Soc., 1982, p. 87-90.
49. Hasking G, Esler M, Jennings G, Burton D, Johns J, Korner P. Norepinephrine spillover to plasma in congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73: 615-621, 1986. (Pubitemid 16081418)
50. Hasking GJ, Esler MD, Jennings GL, Dewar E, Lambert G. Norepinephrine spillover to plasma during steady-state supine bicycle exercise: comparison, of patients with congestive heart failure and normal subjects. Circulation 78: 516-521, 1988. (Pubitemid 18211271)
51. Hoobler SW, Manning JT, Paine WG, Helcher PO, Renfert H, Jr, Peet MM, Kahn EA. The effects of splanchnicectomy on the blood. pressure in hypertension; a controlled study. Circulation 4: 173-183, 1951.
52. Huggett RJ, Burns J, Mackintosh AF, Mary DASG. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation, by hypertension. Hypertension 44: 1-6, 2004.
53. Jacob G, Shannon JR, Costa F, Furlan R, Biaggioni I, MosquedaGarcia R, Robertson RM, Robertson D. Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance. Circulation 99: 1706-1712, 1999. (Pubitemid 29162483)
54. Jordan J, Shannon JR, Diedrich A, Black BK, Robertson D. Increased sympathetic activation in idiopathic orthostatic intolerance: role of systemic adrenoreceptor sensitivity. Hypertension 39: 173-178, 2002. (Pubitemid 34098107)
55. Katholi RE. Renal nerves and hypertension: an update. Fed Proc 44: 2846-2850, 1985.
56. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 26: 1257-1263, 1995.
57. Kawachi I, Colditz GA, Ascherio A, Rimm EB, Giovannucci E, Stampfer MJ, Willet WC. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 89: 1992-1997, 1994. (Pubitemid 24142773)
58. Kawachi I, Sparrow D, Vokanas PS, Weiss ST. Symptoms of anxiety and coronary heart disease. The Normative Aging Study. Circulation 90: 2225-2229, 1994. (Pubitemid 24354305)
59. 2dependent activation of α1- and α2-adrenoceptors on renal, sensory nerves. Am J Physiol Regul Integr Comp Physiol 292: R1561-R1572, 2007.
60. Krum H, Schlaich MP, Whitbourn R, Sobotka P, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373: 1275-1281, 2009.
61. Lambert E, Straznicky N, Schlaich MP, Dawood T, Hotchkin E, Esler MD, Lambert GW. Differing patterns of sympathoexcitation in normal weight and obesity-related hypertension. Hypertension 50: 862-868, 2007. (Pubitemid 350287527)
62. Lambert E, Eikelis N, Esler M, Dawood T, Schlaich M, Bayles R, Socratous F, Agrotis A, Jennings G, Lambert G, Vaddadi G. Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome. Circ Arrhythm Electrophysiolh 103-109, 2008.
63. Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med 334: 413-419, 1996. (Pubitemid 26055840)
64. Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, Mark DB, Sheps DS, Taylor CB, Froelicher ES; American Heart Association Prevention Committee of the Council on Cardiovascular Nursing; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention; American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research; American Psychiatric Association. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 118: 1768-1775, 2008.
65. Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, van Huffelen AC, Koomans HA. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 340: 1321-1328, 1999. (Pubitemid 29196594)
66. Loewi O. Über humorale Übertragbarkeit der Herznervenwirkung. I. Mitteilung. Pflügers Arch Gesamte Physiol Menschen Tiere 189: 239-242, 1921.
67. Macefield V, Wallin BG, Vallbo AB. The discharge behaviour of single vasoconstrictor motoneurones in human muscle nerves. J Physiol 481: 799-809, 1994.
68. Mansour VM, Wilkinson DJC, Jennings GL, Schwarz RG, Thompson JM, Esler MD. Panic disorder: coronary spasm as a basis for cardiac risk? Med J Aust 168: 390-392, 1998.
69. Meredith IT, Esler MD, Cox HS, Lambert GW, Jennings GL, Eisenhofer G. Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure. Clin Autonom Res 1: 187-194, 1991.
70. Meredith IT, Eisenhofer G, Lambert GW, Jennings GL, Esler MD. Plasma noradrenaline responses to head-up tilt are misleading in autonomic failure. Hypertension 19: 628-633, 1992.
71. Micutkova L, Krepsova K, Sabban E, Krizanova O, Kvetnansky R. Modulation of catecholamine-synthesizing enzymes in the rat heart by repeated immobilization stress. Ann NY Acad Sci 1018: 424-429, 2004. (Pubitemid 38951436)
72. Mohaupt MG, Schmidli J, Luft FC. Management of uncontrollable hypertension with a carotic sinus stimulation device. Hypertension 50: 825-828, 2007. (Pubitemid 350287517)
73. Morris MJ, Cox HS, Lambert GW, Kaye DM, Jennings GL, Meredith IT, Esler MD. Region-specific plasma NPY concentrations and overflows at rest and during sympathetic activation in man. Hypertension 29: 137-143, 1997.
74. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease. Arch Gen Psychiatry 55: 580-592, 1998.
75. Newton GE, Parker JD. Cardiac sympathetic response to acute vasodilatation: normal ventricular function versus congestive cardiac failure. Circulation 94: 3161-3167, 1996.
76. Packer M, Bristow MR, Colucci WS, Fowler Gilbert EM MB, Shusterman NH. The effect of Carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334: 1349-1355, 1996. (Pubitemid 26152713)
77. Petersson MJ, Rundqvist B, Johansson M, Eisenhofer G, Lambert G, Herlitz H, Jensen G, Friberg P. Increased cardiac sympathetic drive in renovascualr hypertension. J Hypertens 20: 1181-1187, 2002. (Pubitemid 34913638)
78. Petersson M, Friberg P, Eisenhofer G, Lambert G, Rundqvist B. Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J 26: 906-9134, 2005.
79. Ramchandra R, Hood SG, Denton D, Woods RL, McKinley MJ, McAUen RM, May CN. Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure. Proc Natl Acad Sci USA. 106: 924-928, 2008.
80. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99: 2192-2217, 1999. (Pubitemid 29196806)
81. Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, Wiesner GH, Brunner-La Rocca HP, Esler MD. Neural mechanisms in human obesity-related hypertension. J Hypertens 17: 1125-1133, 1999. (Pubitemid 29389560)
82. Rundqvist B, Elam M, Bergmann-Sverrirsdottir Y, Eisenhofer G, Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 95: 169-175, 1997. (Pubitemid 27029959)
83. Sato H, Tateishi H, Uchida T, Dote K, Ishihara M. Tako-tsubo-like left ventricular dysfunction due to multivessel coronary spasm. In: Clinical Aspect of Myocardial Injury: From Ischemia to Heart Failure, edited by Kodama K, Haze K, and Hori M. Tokyo: Kagakuhyoronsha, 1990, p. 56-64.
84. Schlaich MP, Sobotka PA, Kram H, Lambert E, Esler MD. Renal sympathetic nerve ablation for the treatment of uncontrolled hypertension. N Engl J Med 361: 932-934, 2009.
85. Shibao C, Gamboa A, Diedrich A, Ertl AC, Chen KY, Byrne DW, Farley G, Paranjape SY, Davis SN, Biaggioni I. Autonomic contribution to blood pressure and metabolism in obesity. Hypertension 49: 27-33, 2007. (Pubitemid 46360337)
86. Smithwick RH, Bush RD, Kinsey D, Whitelaw GP. Hypertension and associated cardiovascular disease; comparison of male and female mortality rates and their influence on selection of therapy. JAMA 160: 1023-1026, 1956.
87. Steptoe A, Willemsen G. The influence of job control on ambulatory blood pressure and perceived stress over the working day in men and women from the Whitehall II cohort. J Hypertens 22: 915-920, 2004. (Pubitemid 38680465)
88. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 41: 233-243, 1978. (Pubitemid 8318642)
89. Thompson JM, O'Callaghan CJ, Kingwell BA, Lambert GW, Lennings GL, Esler MD. Total, norepinephrine spillover, muscle sympathetic nerve activity and heart rate spectral analysis in a patient with dopamine-beta-hydroxylase deficiency. J Auton Nerv Syst 55: 198-206, 1995.
90. Vaddadi G, Lambert E, Corcoran SJ, Esler MD. Postural syncope: mechanisms and management. Med J Aust 187: 299-304, 2007.
91. von Euler US. A specific sympathetic ergone in adrenergic nerve fibres (sympathin) and its relation to adrenaline and noradrenaline. Acta Physiol Scand 12: 73-97, 1946.
92. von Euler US, Hellner S, Purkhold A. Excretion of noradrenaline in the urine in hypertension. Scand J Clin Lab Invest 6: 54-59, 1954.
93. Wallin BG, Delius W, Hagbarth KE. Comparison of sym pathetic nerve activity in normotensive and hypertensive subjects. Circ Res 33: 9-21, 1973.
94. Wallin BG, Esler M, Dorward P, Eisenhofer G, Ferrier C, Westerman R, Jennings G. Simultaneous measurements of cardiac norepinephrine spillover and sympathetic outflow to skeletal muscle in humans. J Physiol 453: 45-56, 1992.
95. Wilbert-Lampen U, Leistner D, Greven S, Pohl T, Sper S, Volker C, Guthlin D, Plasse A, Knez A, Kuchenhoff H, Steinbeck G. Cardiovascular events during World Cup soccer. N Engl J Med 358: 475-1383, 2008. (Pubitemid 351185803)
96. Wilkinson DJC, Thompson JM, Lambert GW, Jennings GL, Schwarz RG, Jefferys D, Turner AG, Esler MD. Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress and during panic attacks. Arch Gen Psychiatry 55: 511-520, 1998. (Pubitemid 28272293)
97. Winchester S. A Crack in the Edge of the World: the Great American Earthquake of 1906. London: Penguin, 2005.
98. Wittstein IS, Thiemann DR, Lima JAC, Baughman KL, Schulman SP, Gerstenblith G, Wu JC, Rade JJ, Bivalacqua TJ, Champion PP. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352: 539-548, 2005. (Pubitemid 40204667)
99. Wofford MR, Anderson DC, Brown CA, Jones DW, Miller ME, Hall JE. Antihypertensive effect of α- and β-adrenergic blockade in obese and lean hypertensive subjects. Am J Hypertens 14: 694-698, 2002.
100. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364: 937-952, 2004. (Pubitemid 39208455)
101. Zimmer K. Soul Made Flesh. London: Random House (Arrow Books), 2004, p. 188, 279.